Flexion Therapeutics
FLXN
#7567
Rank
NZ$0.83 B
Marketcap
NZ$16.67
Share price
0.00%
Change (1 day)
8,374.82%
Change (1 year)

Earnings for Flexion Therapeutics (FLXN)

Earnings in 2021 (TTM): -NZ$0.12 Billion

According to Flexion Therapeutics 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2020 the company made an earning of -NZ$0.18 Billion, an increase over its 2019 earnings that were of -NZ$0.25 Billion.

Earnings history for Flexion Therapeutics from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$0.12 Billion-33.42%
2020-NZ$0.18 Billion-29.78%
2019-NZ$0.25 Billion-13.8%
2018-NZ$0.29 Billion21.98%
2017-NZ$0.24 Billion79.92%
2016-NZ$0.13 Billion53.34%
2015-NZ$83.63 Million69.98%
2014-NZ$49.2 Million51.72%
2013-NZ$32.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B-23,681.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.73 B-8,877.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$6.88 M-104.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$32.26 M-122.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$18.81 Million-87.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
-NZ$15.78 Million-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-NZ$0.12 Billion-20.90%๐Ÿ‡บ๐Ÿ‡ธ USA